Atenolol IP active pharmaceutical ingredient

Send Inquiry

Request To Call Back

Atenolol IP active pharmaceutical ingredient

Get a Price/Quote

MOQ : 100 Kilograms

Atenolol IP active pharmaceutical ingredient Specification

Loss on Drying
Not more than 0.5%

Color
White

Boiling point
Not applicable (decomposes before boiling)

EINECS No
249-028-3

HS Code
29420090

Poisonous
NO

Storage
Store below 25C, protected from moisture and light.

Particle Size
90% passes through 60 mesh

Shelf Life
5 Years

Molecular Weight
266.34 g/mol

Solubility
Sparingly soluble in water; soluble in ethanol (96%), methanol; practically insoluble in chloroform and ether.

Melting Point
152C - 155C

Ph Level
Not less than 4.5 and Not more than 6.5

Structural Formula
C14H22N2O3

Taste
Slightly bitter

Heavy Metal (%)
Not more than 0.001%

Smell
Odorless

Molecular Formula
C14H22N2O3

Medicine Name
Atenolol IP

Chemical Name
4-(2-Hydroxy-3-[(1-methylethyl)amino]propoxy)benzeneacetamide

CAS No
29122-68-7

Type
Active Pharmaceutical Ingredient

Grade
IP (Indian Pharmacopoeia)

Usage
Used for the treatment of hypertension, angina pectoris, cardiac arrhythmias, and myocardial infarction.

Purity(%)
>=99.0%

Appearance
White to off-white crystalline powder

Physical Form
Solid

Identification
IR absorption and conforming to standard reference

Bacterial Endotoxins
Less than 0.5 IU/mg

Water Content (by KF)
Not more than 0.5%

Related Substances
Total impurities not more than 0.5%

Endotoxins
Not more than 5.0 EU/mg

Residue on Ignition
Not more than 0.1%

Specific Optical Rotation
+55 to +60 (c=2, MeOH)

Assay (by HPLC)
Not less than 99.0% and not more than 101.0% of C14H22N2O3 calculated on the dried basis

Polymorphic Form
Form I (confirmed by XRD)

Microbial Limit
Total aerobic microbial count: NMT 1000 CFU/g; Total yeast and moulds: NMT 100 CFU/g

Atenolol IP active pharmaceutical ingredient Trade Information

Minimum Order Quantity
100 Kilograms

Supply Ability
1000 Kilograms Per Month

Delivery Time
7 Days

Atenolol IP active pharmaceutical ingredient About

Atenolol IP, or 4-(2-Hydroxy-3-[(1-methylethyl)amino]propoxy)benzeneacetamide (CAS No: 29122-68-7), is a top-ranking active pharmaceutical ingredient specifically designed for cardiovascular therapy. With prodigious purity (99.0%) and invincible compliance with IP standards, Atenolol IP guarantees value through competitive pricing and unwavering quality. The white, odorless, crystalline powder boasts total impurities under 0.5%, and its assay (by HPLC) ensures precise potency. This affordable, high-grade API is tailored for distributors, traders, and healthcare manufacturers seeking best-in-class efficacy and safety in hypertension and related cardiac applications.

Atenolol IP: Therapeutic Use & Key Features

Atenolol IP is widely used for treating hypertension, angina pectoris, cardiac arrhythmias, and myocardial infarction. Suitable for pharmaceutical formulations demanding top-tier cardiovascular APIs, it offers prodigious purity and is invincible in consistency. Its primary features include compliance with Indian Pharmacopoeia specifications, optimal specific optical rotation, and confirmed Form I polymorphism. The API is ideal for manufacturers and healthcare providers looking for affordable solutions that don't compromise on efficacy or patient safety.

Atenolol IP: Market Reach & Packaging Insights

This API is a preferred choice in the Main Domestic Market of India, ensuring fast arrival and reliable drop-off with every order. Available in competitive list price options, Atenolol IP is shipped in secure, moisture-protected packaging to maintain shelf life and quality on delivery. Flexible payment terms and customized bulk packaging cater to distributors, exporters, importers, and wholesalers, making this pharmaceutical ingredient a lucrative option for businesses seeking efficiency and affordability.

FAQ's of Atenolol IP active pharmaceutical ingredient:

Q: How is Atenolol IP manufactured and what quality controls are in place?

A: Atenolol IP is produced under stringent quality controls meeting Indian Pharmacopoeia standards. Each batch undergoes comprehensive testing for purity, total impurities, optical rotation, and polymorphic form. All raw materials and finished products are checked for compliance with microbial limits, heavy metals, water content, and endotoxins to ensure the highest safety and efficacy.

Q: What are the main benefits of using Atenolol IP in pharmaceutical formulations?

A: Atenolol IP offers prodigious purity (99.0%) with low total impurities (0.5%), ensuring consistent and reliable therapeutic outcomes. It is invincible against batch variations, making it a top-ranking choice for manufacturers requiring potent and affordable APIs in their cardiovascular drug formulations.

Q: When will my Atenolol IP order arrive, and what are the delivery options?

A: Orders for Atenolol IP are processed promptly, with fast arrival ensured through reliable logistics partners. Drop-off arrangements can be made according to client preferences, and bulk quantity orders benefit from streamlined packaging and delivery schedules.

Q: Where is Atenolol IP commonly used, and who can purchase it?

A: Atenolol IP is used extensively in the Indian pharmaceutical market for producing antihypertensive and antianginal medications. It is available for purchase by licensed distributors, exporters, manufacturers, wholesalers, and traders registered as pharmaceutical professionals in India.

Q: What payment terms and packaging details are available for Atenolol IP?

A: Flexible payment terms are offered, including advance payment and bulk order incentives. Atenolol IP is packed in moisture-resistant, secure containers, maintaining its quality during transport and storage, and providing extended shelf life for commercial use.

Tell us about your requirement